The Latest Breaking News from Gene Therapy

Biotech stocks are surging as groundbreaking neuroscience and gene therapy innovations take center stage. Amid this backdrop, investors might consider adding fundamentally strong biotech stocks like Regeneron Pharmaceuticals (REGN), Biogen (BIIB), and Gilead Sciences (GILD) to their portfolio for an impactful investment. Continue reading….

The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and improve treatment options. Given this favorable trend, it could be wise to watch strong pharma stocks such as Vertex Pharmaceuticals (VRTX), Wave Life Sciences (WVE), and Poseida Therapeutics (PSTX). Read more.

The promise of gene therapy looms large for families dealing with rare, genetic disorders

Individually, rare diseases are rare, but there are so many rare diseases that over 400 million people are affected worldwide. Together, rare diseases aren’t so rare.

Given as an infusion into the ear, the treatment works by replacing the faulty DNA which causes a type of inherited deafness known as DFNB9.

Study participants born unable to hear could locate sound sources, recognise speech and dance to music after treatment

After the gene therapy, the children went from being profoundly deaf to having mild to moderate hearing loss

For countless families in India, rare diseases are a crippling burden. Affecting less than 1 in 50,000 individuals, these conditions often leave patients and doctors entangled in a frustrating diagnostic labyrinth. Traditional methods can lead to delays and misdiagnosis, further jeopardizing timely intervention. However, a beacon of hope emerges in…

The Lovatos relocated from Guatemala to Ohio for their son, who has the rare genetic disorder Canavan disease